Search

Search Constraints

You searched for: Date 2020 Journal Cancer communications

Search Results

5. A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors. Issue 8 (26th June 2020)

9. Analysis of the Global Burden of Disease study highlights the trends in death and disability‐adjusted life years of leukemia from 1990 to 2017. Issue 11 (16th September 2020)